Article Text

Download PDFPDF
Response to ‘Abatacept in relapsing polychondritis’ by Moulis et al
  1. Stanford L Peng,
  2. Donald Rodriguez
  1. Benaroya Research Institute at Virginia Mason Medical Center, Seattle, Washington, USA
  1. Correspondence to Stanford L Peng, Benaroya Research Institute at Virginia Mason Medical Center, Seattle, Washington 98101, USA; stanford.peng{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We were pleased to learn of Moulis et al's update on their experience with abatacept in three patients with relapsing polychondritis, particularly as their disease manifestations reflected the same manifestations suggested in our study to be of greatest interest for abatacept: chondritis and peripheral arthritis.1 Interestingly, one patient achieved a complete, while another achieved only a partial, corticosteroid-sparing response, and …

View Full Text


  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles

  • Electronic pages
    Guillaume Moulis Grégory Pugnet Laurent Sailler Leonardo Astudillo Philippe Arlet